Leistungen
A final report on the Liaison activities with external stakeholders will be prepared.
1st scientific report on Structure Activity Relationship studies2nd report on reviews of QMS of EU-NCL
2nd scientific report on mode of action studies
Liaison activities with external stakeholders – 1st report
2nd Prioritized list of candidate technologies
3rd report on reviews of QMS of EU-NCL
1st completed survey with regulatory bodies
Activities to promote innovation through partnership with industry– 3rd report
2nd Completed survey with regulatory bodies
1st report on reviews of QMS of EU-NCL
CMS implemented
1st Data management plan
1st List of candidate technologies
2nd Data management plan
2nd report on the testing and optimization of novel technologies
1st report on modeling of analytical decision process
3rd Completed survey with regulatory bodies
3rd Data Management Plan
3rd Sample Management Report
1st report on the testing and optimization of novel technologiesActivities to promote innovation through partnership with industry – 2nd report
Activities to promote innovation through partnership with industry– 2nd report
Activities to promote innovation through partnership with industry– 1st report2nd List of candidate technologies
2nd scientific report on Structure Activity Relationship studies
1st Prioritized list of candidate technologies
1st scientific report on mode of action studies
2nd report on modeling of analytical decision process
EU-NCL annual workshop –year 3
Publication of 1st TNA open call
Publication of “State-of-the-art” manuscript – version 1
EU-NCL annual workshop –year 2
Publication of “State-of-the-art” manuscript – version 2
EU-NCL annual workshop – year 4
EU-NCL website
Publication of 3rd TNA open call
Veröffentlichungen
Autoren:
Dora Mehn, Patrizia Iavicoli, Noelia Cabaleiro, Sven Even Borgos, Fanny Caputo, Otmar Geiss, Luigi Calzolai, François Rossi, Douglas Gilliland
Veröffentlicht in:
International Journal of Pharmaceutics, Ausgabe 523/1, 2017, Seite(n) 320-326, ISSN 0378-5173
Herausgeber:
Elsevier BV
DOI:
10.1016/j.ijpharm.2017.03.046
Autoren:
Fanny Caputo, Amandine Arnould, Maria Bacia, Wai Li Ling, Emilie Rustique, Isabelle Texier, Adriele Prina Mello, Anne-Claude Couffin
Veröffentlicht in:
Molecular Pharmaceutics, Ausgabe 16/2, 2018, Seite(n) 756-767, ISSN 1543-8384
Herausgeber:
American Chemical Society
DOI:
10.1021/acs.molpharmaceut.8b01033
Autoren:
Sabrina Gioria, Fanny Caputo, Patricia Urbán, Ciarán Manus Maguire, Susanne Bremer-Hoffmann, Adriele Prina-Mello, Luigi Calzolai, Dora Mehn
Veröffentlicht in:
Nanomedicine, Ausgabe 13/5, 2018, Seite(n) 539-554, ISSN 1743-5889
Herausgeber:
Future Medicine Ltd.
DOI:
10.2217/nnm-2017-0338
Autoren:
D. Mehn, F. Caputo, M. Rösslein, L. Calzolai, F. Saint-Antonin, T. Courant, P. Wick, D. Gilliland
Veröffentlicht in:
RSC Advances, Ausgabe 7/44, 2017, Seite(n) 27747-27754, ISSN 2046-2069
Herausgeber:
Royal Society of Chemistry
DOI:
10.1039/c7ra02432k
Autoren:
F. Caputo, J. Clogston, L. Calzolai, M. Rösslein, A. Prina-Mello
Veröffentlicht in:
Journal of Controlled Release, Ausgabe 299, 2019, Seite(n) 31-43, ISSN 0168-3659
Herausgeber:
Elsevier BV
DOI:
10.1016/j.jconrel.2019.02.030
Autoren:
Matthias Rösslein, Neill J. Liptrott, Andrew Owen, Patrick Boisseau, Peter Wick, Inge K. Herrmann
Veröffentlicht in:
Nanotoxicology, Ausgabe 11/2, 2017, Seite(n) 147-149, ISSN 1743-5390
Herausgeber:
Informa Healthcare
DOI:
10.1080/17435390.2017.1279361
Autoren:
Adriele Prina-Mello
Veröffentlicht in:
Handbook of Nanomaterials for Cancer Theranostics, 2018, Seite(n) 517-535, ISBN 9780-128133392
Herausgeber:
Elsevier
DOI:
10.1016/b978-0-12-813339-2.00017-7
Suche nach OpenAIRE-Daten ...
Bei der Suche nach OpenAIRE-Daten ist ein Fehler aufgetreten
Es liegen keine Ergebnisse vor